PACS Group (PACS) director Mark Hancock sells 25,304 shares in 10b5-1 plan trades

Rhea-AI Filing Summary

PACS Group, Inc. director and ten-percent owner Mark Hancock reported open-market sales of common stock totaling 25,304 shares on July 8–9, 2026, at weighted average prices of about $45 per share. After these transactions, he directly holds more than 53.9 million shares of PACS Group common stock. The sales were effected pursuant to a Rule 10b5-1 trading plan and were executed in multiple trades within disclosed price ranges.

Insights

Equity governance analyst

Pre-planned insider sales of a small fraction of a large stake.

Director and ten-percent owner Mark Hancock sold 25,304 PACS Group common shares in open-market trades at weighted average prices near $45 per share. These sales were executed under a Rule 10b5-1 trading plan, indicating they were pre-scheduled rather than opportunistic.

Following the trades, Hancock still directly owns about 53.9 million shares, so the dispositions represent only a very small portion of his overall position. Prices were achieved within ranges of $45.00 to $45.2861 and $45.00 to $45.255 per share across multiple transactions on July 8–9, 2026.

Insider Trade Summary 10b5-1

Net Seller: 25,304 shares ($1,140,393)

Net Sell 2 txns

Insider Hancock Mark

Role null

Sold 25,304 shs ($1.14M)

Type	Security	Shares	Price	Value
Sale	Common Stock	4,966	$45.0627	$224K
Sale	Common Stock	20,338	$45.0689	$917K

Holdings After Transaction: Common Stock — 53,920,512 shares (Direct, null)

Footnotes (1)

1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.2861 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.255 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold July 8, 2026: 20,338 shares Shares sold July 9, 2026: 4,966 shares Total shares sold: 25,304 shares +5 more

8 metrics

Shares sold July 8, 2026 20,338 shares Open-market sale of PACS common stock at weighted average price

Shares sold July 9, 2026 4,966 shares Open-market sale of PACS common stock at weighted average price

Total shares sold 25,304 shares Aggregate of reported open-market sales in this Form 4

Weighted avg price July 8 sale $45.0689 per share PACS common stock weighted average sale price on July 8, 2026

Weighted avg price July 9 sale $45.0627 per share PACS common stock weighted average sale price on July 9, 2026

Price range July 8 trades $45.00 to $45.255 per share Range of individual trade prices for July 8, 2026 sales

Price range July 9 trades $45.00 to $45.2861 per share Range of individual trade prices for July 9, 2026 sales

Shares owned after transactions 53,920,512 shares Direct PACS common stock holdings after the reported sales

Key Terms

Rule 10b5-1 trading plan, weighted average price, open-market sale

3 terms

Rule 10b5-1 trading plan regulatory

"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/10/2026 - 06:18 PM Accepted by SEC EDGAR 07/10/2026 - 06:18 PM Learn about SEC filing dates

FAQ

What insider transactions did PACS (PACS Group, Inc.) report for Mark Hancock?

Mark Hancock reported selling 25,304 PACS common shares in open-market transactions on July 8–9, 2026, at weighted average prices around $45 per share. The trades were executed under a Rule 10b5-1 trading plan.

At what prices did Mark Hancock sell PACS (PACS Group, Inc.) shares?

Hancock’s 25,304 PACS shares were sold at weighted average prices of $45.0627 and $45.0689 per share. Individual trades occurred within ranges from $45.00 up to $45.2861 per share.

How many PACS (PACS Group, Inc.) shares does Mark Hancock own after the reported sales?

After the reported transactions, Mark Hancock directly owns 53,920,512 PACS common shares. The 25,304 shares sold represent only a very small fraction of his remaining holdings.

Were the PACS (PACS Group, Inc.) insider sales by Mark Hancock under a Rule 10b5-1 plan?

Yes. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Mark Hancock on March 11, 2026, indicating the transactions were pre-arranged.

What is the total volume of PACS (PACS Group, Inc.) shares sold by Mark Hancock in this Form 4?

In this Form 4, Mark Hancock sold a total of 25,304 PACS common shares, consisting of 20,338 shares on July 8, 2026, and 4,966 shares on July 9, 2026.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hancock Mark

(Last) (First) (Middle)

C/O PACS GROUP, INC.

90 S. 400 W. SUITE 700

(Street)

SALT LAKE CITY UTAH 84101

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PACS Group, Inc. [ PACS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/08/2026		S(1)		20,338	D	$45.0689(2)	53,925,478	D
Common Stock	07/09/2026		S(1)		4,966	D	$45.0627(3)	53,920,512	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026.

2. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.2861 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.255 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ John Mitchell, Attorney-in-Fact	07/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)